Co–Investigator for “A double blind randomised Placebo controlled parallel group study to establish therapeutic equivalence 1000mg Mesalamine rectal suppositories and canasa suppositories in the treatment of Mild to Moderate Ulcerative Proctitis“ (Protocol No. MESA-ULP3125).